|
[1] SWEET PH,KHOO T,NGUYEN S. Nonalcoholic fatty liver disease[J]. Prim Care,2017,44(4):599-607.
|
|
[2] YOUNOSSI ZM,KOENIG AB,ABDELATIF D,et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence,incidence,and outcomes[J].Hepatology,2016,64(1):73-84.
|
|
[3] YOUNOSSI Z,ANSTEE QM,MARIETTI M,et al. Global burden of NAFLD and NASH:Trends,predictions,risk factors and prevention[J]. Nat Rev Gastroenterol Hepatol,2018,15(1):11-20.
|
|
[4] YOUNOSSI ZM. Non-alcoholic fatty liver disease-A global public health perspective[J]. J Hepatol,2019,70(3):531-544.
|
|
[5] PALMER ND,MUSANI SK,YERGES-ARMSTRONG LM,et al. Characterization of European ancestry nonalcoholic fatty liver disease-associated variants in individuals of African and Hispanic descent[J]. Hepatology,2013,58(3):966-975.
|
|
[6] SZANTO KB,LI J,CORDERO P,et al. Ethnic differences and heterogeneity in genetic and metabolic makeup contributing to nonalcoholic fatty liver disease[J]. Diabetes Metab Syndr Obes,2019,12:357-367.
|
|
[7] KALIA HS,GAGLIO PJ. The prevalence and pathobiology of nonalcoholic fatty liver disease in patients of different races or ethnicities[J]. Clin Liver Dis,2016,20(2):215-224.
|
|
[8] HU XY,LI Y,LI LQ,et al. Risk factors and biomarkers of non-alcoholic fatty liver disease:An observational cross-sectional population survey[J]. BMJ Open, 2018, 8(4):e019974.
|
|
[9] YOUNOSSI Z,TACKE F,ARRESE M,et al. Global perspectives on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis[J]. Hepatology,2019,69(6):2672-2682.
|
|
[10] FARZANEGI P,DANA A,EBRAHIMPOOR Z,et al. Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease(NAFLD):Roles of oxidative stress and inflammation[J]. Eur J Sport Sci,2019,19(7):994-1003.
|
|
[11] KATO A,LI Y,OTA A,et al. Smoking results in accumulation of ectopic fat in the liver[J]. Diabetes Metab Syndr Obes,2019,12:1075-1080.
|
|
[12] TER HORST KW,SERLIE MJ. Fructose consumption,lipogenesis,and non-alcoholic fatty liver disease[J]. Nutrients,2017,9(9):e981.
|
|
[13] CHAKRABORTY A,CHOUDHURY A,SAHA A. Development of non-alcoholic fatty liver disease(NAFLD)in young obese tribal subjects of Tripura:Link between low 25(OH)vitamin-D levels and immune modulators[J]. J Assoc Physicians India,2019,67(8):52-56.
|
|
[14] KOPLAY M,GULCAN E,OZKAN F. Association between serum vitamin B12 levels and the degree of steatosis in patients with nonalcoholic fatty liver disease[J]. J Investig Med,2011,59(7):1137-1140.
|
|
[15] PAN X,CHEN B,LIU W,et al. Circulating iron levels interaction with central obesity on the risk of nonalcoholic fatty liver disease:A case-control study in southeast China[J]. Ann Nutr Metab,2019,74(3):207-214.
|
|
[16] AIGNER E,WEISS G,DATZ C. Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver[J]. World J Hepatol,2015,7(2):177-188.
|
|
[17] LEE SH,KIM MJ,KIM YS,et al. Low hair copper concentration is related to a high risk of nonalcoholic fatty liver disease in adults[J]. J Trace Elem Med Biol,2018,50:28-33.
|
|
[18] NCD Risk Factor Collaboration(NCD-Ris C). Trends in adult body-mass index in 200 countries from 1975 to 2014:A pooled analysis of 1698 population-based measurement studies with 19. 2 million participants[J]. Lancet,2016,387(10026):1377-1396.
|
|
[19] ARGO CK,HENRY ZH. Editoria:l “Lean”NAFLD:Metabolic obesity with normal BMI…Is it in the genes?[J]. Am J Gastroenterol,2017,112(1):111-113.
|
|
[20] FAN JG,KIM SU,WONG VW. New trends on obesity and NAFLD in Asia[J]. J Hepatol,2017,67(4):862-873.
|
|
[21] SHAO C,YE J,LI F,et al. Different predictors of steatosis and fibrosis severity among lean,overweight and obese patients with nonalcoholic fatty liver disease[J]. Dig Liver Dis,2019,51(10):1392-1399.
|
|
[22] YANG H,LI D,SONG X,et al. Joint associations of serum uric acid and ALT with NAFLD in elderly men and women:A Chinese cross-sectional study[J]. J Transl Med,2018,16(1):285.
|
|
[23] ZHOU Y,WEI F,FAN Y. High serum uric acid and risk of nonalcoholic fatty liver disease:A systematic review and metaanalysis[J]. Clin Biochem,2016,49(7-8):636-642.
|
|
[24] BRUNO ADE S,RODRIGUES MH,ALVARES MC,et al. Non-alcoholic fatty liver disease and its associated risk factors in Brazilian postmenopausal women[J]. Climacteric,2014,17(4):465-471.
|
|
[25] LI B,ZHANG C,ZHAN YT. Nonalcoholic fatty liver disease cirrhosis:A review of its epidemiology,risk factors,clinical presentation,diagnosis,management,and prognosis[J].Can J Gastroenterol Hepatol,2018,2018:2784537.
|
|
[26] NOUREDDIN M,YATES KP,VAUGHN IA,et al. Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients[J]. Hepatology,2013,58(5):1644-1654.
|
|
[27] ALKHOURI N,POORDAD F,LAWITZ E. Management of nonalcoholic fatty liver disease:Lessons learned from type 2 diabetes[J]. Hepatol Commun,2018,2(7):778-785.
|
|
[28] POREPA L,RAY JG,SANCHEZ-ROMEU P,et al. Newly diagnosed diabetes mellitus as a risk factor for serious liver disease[J]. CMAJ,2010,182(11):e526-e531.
|
|
[29] MARENGO A,JOUNESS RI,BUGIANESI E. Progression and natural history of nonalcoholic fatty liver disease in adults[J].Clin Liver Dis,2016,20(2):313-324.
|
|
[30] SAID A,GHUFRAN A. Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma[J]. World J Clin Oncol,2017,8(6):429-436.
|
|
[31] LEE S,ZHANG C,LIU Z,et al. Network analyses identify liver-specific targets for treating liver diseases[J]. Mol Syst Biol,2017,13(8):938.
|
|
[32] DALAMAGA M,DIAKOPOULOS KN,MANTZOROS CS. The role of adiponectin in cancer:A review of current evidence[J]. Endocr Rev,2012,33(4):547-594.
|
|
[33] ZOLLER H,TILG H. Nonalcoholic fatty liver disease and hepatocellular carcinoma[J]. Metabolism,2016,65(8):1151-1160.
|
|
[34] SORRENTINO P,D’ANGELO S,FERBO U,et al. Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis[J]. J Hepatol,2009,50(2):351-357.
|
|
[35] HASSAN MM,ABDEL-WAHAB R,KASEB A,et al. Obesity early in adulthood increases risk but does not affect outcomes of hepatocellular carcinoma[J]. Gastroenterology,2015,149(1):119-129.
|
|
[36] TOMITA K,TERATANI T,SUZUKI T,et al. Free cholesterol accumulation in hepatic stellate cells:Mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice[J].Hepatology,2014,59(1):154-169.
|
|
[37] SAFIRI S,KHAZAEI S,MANSORI K,et al. Comments on“Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease:Systematic review and meta-analysis”[J].Hepatology,2017,66(4):1358-1359.
|
DownLoad: